Advertisement

Psychopharmacology

, Volume 217, Issue 3, pp 453–454 | Cite as

Nicotine preloading: the importance of a pre-cessation reduction in smoking behavior

  • Jed E. RoseEmail author
Letter to the Editors

In their recent article in Psychopharmacology, Lindson and Aveyard (2011) present an extensive analysis of nicotine “preloading,” or initiation of nicotine replacement therapy (NRT) during the weeks prior to a target quit date. They conclude that there is only a weak beneficial effect of nicotine preloading on smoking abstinence, and that there is a great deal of variability in results across studies. Moreover, they examine several variables as potential moderators and mediators of the effect of nicotine preloading, but conclude that none of these variables convincingly explains the efficacy of this treatment strategy.

While thorough in many respects, however, the review does not include a growing body of evidence identifying pre-cessation smoking reduction as a key variable that is highly predictive of the therapeutic effects of pre-cessation NRT. Some of this evidence has been published since the date of submission of the Lindson and Aveyard (2011) review and some was presented in...

Keywords

Nicotine Nicotine Replacement Therapy Varenicline Nicotine Patch Abstinence Rate 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Notes

Disclosure

This work was supported by National Institute on Drug Abuse grant 5P50 DA027840-01. The author also receives grant funding from Philip Morris USA.

References

  1. Lindson N, Aveyard P (2011) An updated meta-analysis of nicotine preloading for smoking cessation: investigating mediators of the effect. Psychopharmacology (Berl) 214(3):579–592. doi: 10.1007/s00213-010-2069-3 CrossRefGoogle Scholar
  2. McClernon FJ, Huettel SA, Rose JE (2005) Abstinence-induced changes in self-report craving correlate with event-related fMRI responses to smoking cues. Neuropsychopharmacology 30(10):1940–1947. doi: 10.1038/sj.npp.1300780 PubMedCrossRefGoogle Scholar
  3. Rose JE, Herskovic JE, Behm FM, Westman EC (2009) Pre-cessation treatment with nicotine patch significantly increases abstinence rates relative to conventional treatment. Nicotine Tob Res 11(9):1067–1075. doi: 10.1093/ntr/ntp103 PubMedCrossRefGoogle Scholar
  4. Rose JE, Behm FM, Drgon T, Johnson C, Uhl GR (2010) Personalized smoking cessation: interactions between nicotine dose, dependence and quit success genotype score. Mol Med 16(7–8):247–253. doi: 10.2119/molmed.2009.00159 PubMedGoogle Scholar
  5. Rose JE, Behm FM, Walther DM, Johnson C, Uhl GR (2011) Personalized and adaptive treatment for smoking cessation. Poster presented at the Annual Meeting of the Society for Research on Nicotine and Tobacco 2011, Toronto, ON, CAGoogle Scholar
  6. Shiffman S, Scharf DM, Shadel WG, Gwaltney CJ, Dang Q, Paton SM, Clark DB (2006) Analyzing milestones in smoking cessation: illustration in a nicotine patch trial in adult smokers. J Consult Clin Psychol 74(2):276–285. doi: 10.1037/0022-006X.74.2.276 PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2011

Authors and Affiliations

  1. 1.Center for Nicotine and Smoking Cessation ResearchDuke University Medical CenterDurhamUSA

Personalised recommendations